COMPARATIVE EFFICACY OF BETAHISTINE VERSUS CINNARIZINE IN VERTIGO MANAGEMENT: A RANDOMIZED CONTROLLED TRIAL
- Senior Consultantand Head-Dept of Internal Medicine, Park Super Specialty Hospital, Faridabad, Haryana - 121006.
- Senior Consultant, Department of ENT, Park Super Specialty Hospital, Faridabad, Haryana 121006.
- Senior Consultant, Department of Critical Care, Park Super Specialty Hospital, Faridabad, Haryana 121006.
- Abstract
- Keywords
- Cite This Article as
- Corresponding Author
Background: Vertigo, often arising from peripheral vestibular dysfunction (e.g., BPPV, vestibular neuritis, Menieres disease), causes debilitating dizziness, nausea, and imbalance. Betahistine and cinnarizine are widely used vestibular suppressants, but direct comparisons in acute vertigo settings remain limited.
Objective: To compare the speed of symptom relief and tolerability of betahistine versus cinnarizine over four weeks in adults with vertigo. Methods: In a double blind trial, 100 patients (aged 18 65; symptom onset 4 weeks baseline VAS 1) were randomized to betahistine (8 mg tid; 24 mg/day) or cinnarizine (25 mg tid; 75 mg/day) for four weeks. Daily VAS, Mean Vertigo Score (MVS), and Mean Concomitant Symptom Score (MCSS) were recorded through Day 7. Efficacy (5 point verbal) was assessed on Days 3 and 7; tolerability (4 point) was evaluated on Day 3, Week 1, and Week 4. Analyses used tests (or Mann Whitney U), chi square tests, and Kaplan Meier/log rank for time to improvement.
[Vaijinath Raghunath Dhapase, Harsh Vardhan Singh and Prashant Bhatia (2025); COMPARATIVE EFFICACY OF BETAHISTINE VERSUS CINNARIZINE IN VERTIGO MANAGEMENT: A RANDOMIZED CONTROLLED TRIAL Int. J. of Adv. Res. (May). 1470-1474] (ISSN 2320-5407). www.journalijar.com
